Xeolas Leadership Team
Damien Flynn
Founder & Chief Executive Officer
- Qualified pharmacist with an MSc. in Biotechnology
- Over 25 years’ experience in the global pharmaceutical industry including senior roles in Arrow Pharmaceuticals (Teva), Merck Generics (Mylan), GSK and Elan Pharmaceuticals
- Significant experience in site management, R&D, and business development
- Damien founded Xeolas Pharmaceuticals with the vision of becoming a world leader in developing patient friendly medicines and bringing innovation to the space between big pharma and generics
Dr Dennis McDaid
Technical Director
- Qualified Pharmacist with a PhD in Pharmaceutics
- Over 25 years’ experience in the global pharmaceutical industry including Alza Corporation (J&J), Forest Laboratories, GSK and Baxter with significant experience in site management, R&D, quality and regulatory
- As Technical Director, Dennis has responsibility for the R&D, clinical, quality, and regulatory functions
- Dennis thrives in complex formulation challenges and his vision for Xeolas is to be the recognised leader in the development of innovative solutions for unmet patient needs
Joanne Weldon
Finance Director
- Qualified Chartered Accountant with an MSc. in Management Principles and Practices
- Over 20 years’ experience in global pharmaceutical finance including EU Finance Director, Forest Laboratories
- As Finance Director, Joanne has overall responsibility for Finance, IT and HR functions
- Joanne’s vision is for Xeolas to become a world leader in developing and delivering patient friendly medicine. She is dedicated to supporting this vision by directing the activities of the finance function to build a growth orientated, profitable business with a focus on creating value for the long term
Dolores Lynch
Operations Director
- Chemical Engineer with a diploma in Strategic Management
- Over 20 years in the global pharmaceutical industry with significant experience in manufacturing and supply-chain including; Supply chain Manager API network, BMS, and Senior supply-chain consultant, High-Tech Health
- As Operations Director, Dolores has functional responsibility for Drug Product Manufacturing and supply
- Dolores’ vision is to build a world class Operations function; she is dedicated to building an agile supply chain to support the manufacture of complex patented technologies and to providing a reliable product supply direct to Xeolas partners around the world
Andrew Broderick
Commercial Director
- Executive MBA from Imperial College Business School, Associate of Chartered Institute of Marketing with a BSc Hons in Biotechnology
- Over 15 years’ experience in global business development in both developed and emerging markets, with Dr. Reddy’s and Pharmathen as head of Europe, CIS and Russia
- As Commercial Director, Andrew has responsibility for Global Development, Portfolio Management and Business Development/Licensing
- Andrew’s vision is for Xeolas to be the go-to partner for the development and supply of innovative medicines meeting unmet needs globally